ENT Medical News about Parathyroid

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Appropriate Antibiotic Use for Acute Otitis Media

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Parathyroid surgery and methylene blue: A review with guidelines for safe intraoperative use
The Laryngoscope, 07/15/09

Pollack G et al. - Methylene blue has been used to help facilitate parathyroid surgery for over 30 years. Its use has been widely considered both safe and cost effective. Twenty-six cases of a toxic metabolic encephalopathy, however, have been reported with its use. As a result, some surgeons have stopped using this technique altogether. It is now known that methylene blue is a monoamine oxidase inhibitor. When combined with drugs that increase central serotonin neurotransmission, serotonin toxicity results.

<< Previous
Molecular resonance vs. coblation tonsillectomy in children

Next >>
Multicenter phase 2 study of induction chemotherapy with...

Cytopathologist-performed ultrasound-guided fine-needle aspiration of parathyroid lesions
Diagnostic Cytopathology, 10/28/09 Relevance Score: 91%

Allotransplant of Microencapsulated Parathyroid Tissue in Severe Postsurgical Hypoparathyroidism: A Case Report
Transplantation Proceedings, 11/17/09 Relevance Score: 88%

Single Photon Emission Computed Tomography (SPECT) Should be Routinely Performed for the Detection of Parathyroid Abnormalities Utilizing Technetium-99m Sestamibi Parathyroid Scintigraphy
Clinical Nuclear Medicine, 10/07/09 Relevance Score: 88%

A Case Report of 20 Lung Radiofrequency Ablation Sessions for 50 Lung Metastases from Parathyroid Carcinoma Causing Hyperparathyroidism
Cardiovascular and Interventional Radiology, 11/10/09 Relevance Score: 87%

What steps should be considered in the patient who has had a negative cervical exploration for primary hyperparathyroidism
Clinical Endocrinology, 10/15/09 Relevance Score: 87%